Differential Maturation and Subcellular Localization of Severe Acute Respiratory Syndrome Coronavirus Surface Proteins S, M and E
Overview
Authors
Affiliations
Post-translational modifications and correct subcellular localization of viral structural proteins are prerequisites for assembly and budding of enveloped viruses. Coronaviruses, like the severe acute respiratory syndrome-associated virus (SARS-CoV), bud from the endoplasmic reticulum-Golgi intermediate compartment. In this study, the subcellular distribution and maturation of SARS-CoV surface proteins S, M and E were analysed by using C-terminally tagged proteins. As early as 30 min post-entry into the endoplasmic reticulum, high-mannosylated S assembles into trimers prior to acquisition of complex N-glycans in the Golgi. Like S, M acquires high-mannose N-glycans that are subsequently modified into complex N-glycans in the Golgi. The N-glycosylation profile and the absence of O-glycosylation on M protein relate SARS-CoV to the previously described group 1 and 3 coronaviruses. Immunofluorescence analysis shows that S is detected in several compartments along the secretory pathway from the endoplasmic reticulum to the plasma membrane while M predominantly localizes in the Golgi, where it accumulates, and in trafficking vesicles. The E protein is not glycosylated. Pulse-chase labelling and confocal microscopy in the presence of protein translation inhibitor cycloheximide revealed that the E protein has a short half-life of 30 min. E protein is found in bright perinuclear patches colocalizing with endoplasmic reticulum markers. In conclusion, SARS-CoV surface proteins S, M and E show differential subcellular localizations when expressed alone suggesting that additional cellular or viral factors might be required for coordinated trafficking to the virus assembly site in the endoplasmic reticulum-Golgi intermediate compartment.
Bedada F, Gorfu G, Teng S, Neita M Front Mol Med. 2024; 2:917201.
PMID: 39157715 PMC: 11328875. DOI: 10.3389/fmmed.2022.917201.
3-chymotrypsin-like protease in SARS-CoV-2.
Al Adem K, Ferreira J, Villanueva A, Fadl S, El-Sadaany F, Masmoudi I Biosci Rep. 2024; 44(8).
PMID: 39036877 PMC: 11300678. DOI: 10.1042/BSR20231395.
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness.
Liu W, Huang Z, Xiao J, Wu Y, Xia N, Yuan Q Viruses. 2024; 16(2).
PMID: 38399960 PMC: 10893260. DOI: 10.3390/v16020184.
Neitthoffer B, Alvarez F, Larrous F, Caillet-Saguy C, Etienne-Manneville S, Boeda B J Biol Chem. 2023; 300(1):105575.
PMID: 38110034 PMC: 10821599. DOI: 10.1016/j.jbc.2023.105575.
Desmarets L, Danneels A, Burlaud-Gaillard J, Blanchard E, Dubuisson J, Belouzard S Cell Mol Life Sci. 2023; 80(12):353.
PMID: 37940699 PMC: 10632273. DOI: 10.1007/s00018-023-05008-y.